Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Applied Materials Appoints Akash Palkhiwala to Board of Directors

August 27, 2026

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

August 27, 2026

PruittHealth Celebrates Senior CNA Graduates at Walt Disney World® Resort

August 27, 2026

Scripps taps NBCU sales veteran to lead small and medium business growth and direct response advertising

August 27, 2026

Metrolinx hikes penalties for fare evasion to $200 and higher

August 27, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » INB.bio Launches 2026 Growth Strategy With New Market Entries Across Africa, MENA and Southeast Asia
Press Release

INB.bio Launches 2026 Growth Strategy With New Market Entries Across Africa, MENA and Southeast Asia

By News RoomMarch 22, 20263 Mins Read
INB.bio Launches 2026 Growth Strategy With New Market Entries Across Africa, MENA and Southeast Asia
Share
Facebook Twitter LinkedIn Pinterest Email

BERLIN, March 22, 2026 (GLOBE NEWSWIRE) — Global demand for wellness products is climbing steadily, with the industry reaching a record $6.8 trillion and projected to hit $9.8 trillion by 2029, and a growing share of that demand is concentrated in emerging markets that global brands have historically underserved. INB.bio, a direct advertiser in dietary and wellness supplements operating across 15 countries in Africa, MENA, and Latin America, has launched its 2026 growth strategy. Plans include a market entry into Tanzania, expansion into three to five new countries across Africa and Southeast Asia, and the rollout of a rebuilt AI-powered affiliate CRM platform designed to support rapid multi-market operations.

The company, which manufactures and distributes an exclusive portfolio of wellness products covering men’s health, joint support, weight management, immunity, and cardiovascular health, enters 2026 having built one of the most operationally complete direct advertiser models in its category. Its infrastructure in each active market includes native call centers, owned logistics networks, and a proprietary technology platform built for cash-on-delivery economies where digital payment access is limited.

“Tanzania is the opening move of 2026,” said Rozhden Totskoinov, Founder of INB.bio. “Africa and Southeast Asia represent the largest untapped opportunity in wellness right now, and we are entering these markets the same way we have always entered them. With people on the ground, owned logistics and technology built for the reality of how these markets actually operate.“

Africa’s middle class is projected to reach 1.1 billion people by 2060, according to the African Development Bank, a demographic shift already driving increased consumer spending on health and lifestyle products across the continent. The global wellness economy recorded $6.8 trillion in 2024 and is on track to reach $9.8 trillion by 2029, per the Global Wellness Institute, with Sub-Saharan Africa and Southeast Asia among the regions where growth is accelerating most notably. INB.bio has positioned its entire operating model around exactly those market characteristics, prioritising regions with COD payment dominance, mobile-first populations, and limited existing competition from established global players.

The company is simultaneously launching a turnkey partner program through which high-performing affiliate partners can co-develop new country operations alongside INB.bio. Participants receive exclusive geographic access, native call center resources, owned logistics support, and live performance data through an upgraded affiliate dashboard. Payouts are processed twice weekly, on Tuesdays and Fridays, with a minimum threshold of fifty dollars in USDT TRC-20, and additional payment options, including wire transfer and PayPal, are in development.

“We are proving that the model we built over six years is repeatable at scale,” said Rozhden. “Tier-2 and tier-3 markets are not too difficult for serious operators. They are simply too difficult for operators unwilling to do the actual work, and 2026 is where we demonstrate what that means at full speed.”

Visit the company’s website for more information.

About INB.bio
INB.bio is a direct advertiser in dietary and wellness supplements operating across 15 countries in Africa, MENA and Latin America. The company manufactures and distributes an exclusive portfolio of wellness products supported by owned infrastructure in every active market, including native call centers, proprietary logistics networks and a custom-built technology platform designed for cash-on-delivery economies. Founded six years ago, INB.bio serves millions of end customers and a global network of affiliate partners through a twice-weekly payout model. The company’s 2026 expansion targets new geographic markets across Africa and Southeast Asia as part of a long-term strategy to build wellness infrastructure across 30 emerging markets worldwide. For more information, visit INB.bio.

Contact:
Paulina Dvor, Senior Content & PR Manager
INB.bio
[email protected]
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/964e46f5-e16e-4577-9b87-f6d9a64eb290

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Applied Materials Appoints Akash Palkhiwala to Board of Directors

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

PruittHealth Celebrates Senior CNA Graduates at Walt Disney World® Resort

Scripps taps NBCU sales veteran to lead small and medium business growth and direct response advertising

Novarad Updates NovaPACS EI Customers Worldwide to 9.1, a Major Security Upgrade

Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project

Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

Troutman Amin, LLP Elevates Former Prosecutor Tori L. Guidry to Partner in Complex Litigation Group

Levanta Raises $22M Series B from Volition Capital to Deploy the Infrastructure for Creator Commerce Media

Editors Picks

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

August 27, 2026

PruittHealth Celebrates Senior CNA Graduates at Walt Disney World® Resort

August 27, 2026

Scripps taps NBCU sales veteran to lead small and medium business growth and direct response advertising

August 27, 2026

Metrolinx hikes penalties for fare evasion to $200 and higher

August 27, 2026

Latest News

Novarad Updates NovaPACS EI Customers Worldwide to 9.1, a Major Security Upgrade

August 27, 2026

Busy Philipps diagnosed with rare brain tumour: ‘Grateful that I’m alive’

August 27, 2026

Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project

August 27, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version